Enabling efficient multi-site working for Severn Pathology Service

Severn Pathology set out to establish a system that would increase standardisation, enable efficient, low-risk collaboration and be fully in line with the Sustainability and Transformation Programme, and latterly the NHSI drive to pathology networking. This meant implementing a single LIMS to support multi-site requirements and enable multiple incumbent IT systems to share information.

AZ Sint-Jan AV Brugge-Oostende, Belgium, DaVinci

Embracing digital pathology, future-oriented pathology lab reaches beyond its hospital walls.

Ketterthill laboratories, Luxembourg

Integrating GLIMS 9 in its innovative robotic track system, Ketterthill improved productivity and speed, supporting opportunities for growth.

Rationalising three different LIMS into a single WinPath Enterprise solution for Barts Health NHS Trust

Barts Health NHS Trust had a mixed estate of LIMS across its sites. The Trust identified that management of multiple systems and hardware platforms was far from optimal, and the migration to a single platform across all sites would improve efficiency and workflow, and would enable all sites to benefit from enhanced WinPath Enterprise functionality.

Assistance Publique – Hôpitaux de Paris (AP-HP), France

GLIMS provides a pooled, evolutive solution that supports all the specialities of AP-HP’s 121 laboratories.

How Covid will shape the coming year and help to change pathology forever

Richard Craven, chief executive of CliniSys, considers how the tumultuous events of 2020 will impact on 2021, and how they will affect the company, the NHS, and the world of pathology for years to come.

14 December 2020

Launch of a new Genomic Laboratory Information Management System – GLIMS Genomics

Following the successful launch of our new Genomic Laboratory Information Management System in Europe and the recent go live at Poitiers University Hospital, France, CliniSys is proud to invite you to the UK premier launch of GLIMS Genomics. This is the first new Genomic LIMS launched in the UK for many years and we hope […]

24 November 2020

MIPS makes an important contribution to the fight against corona in Belgium, the Netherlands, France and Germany

In an effort to control the COVID-19 pandemic and to significantly scale up testing capacity, governments throughout the world have set up screening programmes. In Belgium, the Netherlands, France and Germany, the software systems from MIPS are playing an important role in these programmes by facilitating the communication between the laboratories, the governmental software platforms, and the various agencies that centralise and report on the data.

5 November 2020

MIPS makes an important contribution to the fight against corona in Belgium, the Netherlands, France and Germany

In an effort to control the COVID-19 pandemic and to significantly scale up testing capacity, governments throughout the world have set up screening programmes. In Belgium, the Netherlands, France and Germany, the software systems from MIPS are playing an important role in these programmes by facilitating the communication between the laboratories, the governmental software platforms, […]

22 October 2020

MIPS supports GLIMS customers with pooled testing against SARS-CoV-2

The new coronavirus which causes the COVID-19 illness still has the world under its spell. Medical laboratories worldwide geared up their PCR testing capacity the last months to detect the virus. This testing involves many consumables to perform a PCR-test and comes with logistic challenges for all laboratories worldwide to maximize the throughput in the […]

8 October 2020

What’s important in selecting a LIS for Anatomic Pathology?

If you are about to embark on finding an Anatomic Pathology (AP) LIS supplier, which criteria should you consider when choosing a vendor? Romaric Croes, pathologist and founder of LIS DaVinci and clinical director at MIPS, offers some recommendations.

2 October 2020

CliniSys and Pathology after the Pandemic

Our chief executive, Richard Craven, reflects on some of the profound changes that the novel coronavirus has brought to CliniSys, to healthcare, and to pathology, and how they are likely to play out in a post-Covid future.

21 July 2020